Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ketamine Versus Dexmedetomidine as an Adjuvant in Ultrasound-guided Supraclavicular Brachial Plexus Block


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04508894

Organisation Name: Minia University

Overal Status: Recruiting

Start Date: April 21, 2019

Last Update: September 3, 2020

Lead Sponsor: Minia University

Brief Summary: Intervention model description: The patients were randomly classified into three groups using computer-generated table numbers each contain (25) patients.

Ketamine group (group K): 20 ml 0.5%bupivacaine and 20 ml 0.9% normal saline plus 1 mg\kg ketamine, Dexmedetomidine group (group D): 20 ml 0.5% bupivacaine and 20 ml 0.9% normal saline plus 1µg\kg dexmedetomidine Control group (group C): 20 ml 0.5%bupivacaine and 20 ml 0.9% normal saline. Masking: double-blind (participant and investigator) Masking Description: The investigator's study is a prospective, randomized, double-blind

Conditions:
  • Supraclavicular Brachial Plexus Block


Total execution time in seconds: 0.20940494537354